查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1580871

药物输送系统市场：按输送类型、配方、药物释放机制、应用、最终用户 - 2025-2030 年全球预测

Drug Delivery Systems Market by Delivery Type (Inhalation Drug Delivery, Injection-Based Delivery, Nasal Drug Delivery), Formulation (Gas, Liquid, Semisolid), Drug Release Mechanism, Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年给药系统市值为370.4亿美元，预计到2024年将达到390.2亿美元，复合年增长率为5.70%，到2030年将达到546.1亿美元。

药物传递系统的范围包括用于治疗剂的靶向输送和控制释放的技术。这些系统透过确保药物以最佳浓度到达所需的作用部位，对于提高药物治疗的有效性、安全性和患者依从性至关重要。药物输送系统以多种形式应用，包括口服、注射、经皮、吸入和植入装置，并服务医院、诊所和家庭护理的广泛最终用途。在生物技术和奈米技术进步的推动下，对更精确、更有效率和对患者友好的治疗解决方案的持续需求凸显了对复杂药物传输机制的需求。

主要市场统计
基准年[2023] 370.4亿美元
预测年份 [2024] 390.2亿美元
预测年份 [2030] 546.1亿美元
复合年增长率（%） 5.70%

影响该市场的关键成长要素包括慢性病盛行率的增加、对生技药品和生物相似药的需求不断增长以及输送技术的创新。此外，个人化医疗和生物疗法的兴起为提高标靶效果和生物有效性的新型递送系统提供了重大机会。例如，智慧给药平台和微粒技术等技术创新是高成长的潜在领域。希望利用这些机会的公司应该投资于生物分解性聚合物和奈米载体等尖端系统的研究和开发。然而，市场面临监管复杂性、开发成本高和生物技术知识有限等挑战，抑制了创新和采用的速度。

药物稳定性和患者依从性的限制也是需要解决的障碍。未来的创新应专注于透过加强材料科学和工程的发展以及创建更具适应性和响应性的交付系统来克服这些障碍。探索数位健康技术的协同使用可以进一步完善监测和管理并改善药物传输环境。总体而言，给药系统市场是一个充满活力且充满挑战的市场，需要对技术和监管导航进行策略性投资，以抓住新机会并促进可持续的市场成长。

市场动态：快速发展的给药系统市场的关键市场洞察

供需的动态交互作用正在改变给药系统市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 世界各地慢性病感染疾病流行范围扩大
    • 政府加大对医疗基础建设的支持
    • 个人化医疗需求不断成长
  • 市场限制因素
    • 开发药物输送系统的高成本
  • 市场机会
    • 药物输送系统製造的技术进步
    • 扩大奈米技术在高效标靶药物传输系统的应用
  • 市场挑战
    • 监管障碍和漫长的核准流程

波特五力：驾驭给药系统市场的策略工具

波特的五力框架是了解药物输送系统市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解药物输送系统市场的外部影响

外部宏观环境因素在塑造给药系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解给药系统市场的竞争状况

药物输送系统市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵给药系统市场供应商绩效评估

FPNV 定位矩阵是评估药物传输系统市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划药物输送系统市场的成功之路

药物输送系统市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地慢性病和感染疾病的盛行率正在增加。
      • 加大医疗基础建设投资、政府支持
      • 个人化医疗需求不断成长
    • 抑制因素
      • 开发药物输送系统的高成本
    • 机会
      • 药物输送系统生产的技术进步
      • 扩大奈米技术在高效标靶药物传输系统的应用
    • 任务
      • 监管障碍和漫长的核准流程
  • 市场区隔分析
    • 给药方法：越来越多地采用经皮给药以确保长期、受控的药物释放。
    • 应用：糖尿病的全球流行增加了对持续给药系统的需求。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依输送类型分類的药物输送系统市场

  • 吸入给药
  • 注射输送
  • 鼻内给药
  • 眼科药物输送
  • 口服给药
  • 局部给药
  • 经经皮给药

第七章依製剂分類的给药系统市场

  • 气体
  • 液体
  • 半固体
  • 固体的

第八章依药物释放机制分類的药物输送系统市场

  • 控释
  • 即时释放
  • 持续释放
  • 目标发布

第九章给药系统市场：依应用分类

  • 心血管疾病
  • 中枢神经系统疾病
  • 糖尿病
  • 感染疾病
  • 肿瘤学
  • 呼吸系统疾病

第 10 章 给药系统市场：依最终使用者分类

  • 诊断中心
  • 家庭护理设置
  • 医院/诊所

第十一章 北美和南美给药系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太药物传输系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的给药系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Schott Pharma 和 Koru Medical Systems 合作开发创新药物传输以改善患者照护
    • Difgen 透过收购 FDA 註册设施来提高产量和质量
    • Sharp Corporation Technology 推出新型药物输送系统，可提高病患安全并降低给药风险
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • AptarGroup, Inc.
  • AstraZeneca Plc
  • Boston Scientific Corporation
  • Cospheric LLC
  • DelSiTech Ltd.
  • Enable Injections, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • Merit Medical Systems, Inc.
  • Novartis AG
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Polysciences Inc.
  • Sanofi SA
  • SHL Medical
  • Societal CDMO by CoreRx, Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services, Inc.
Product Code: MRR-CA7E340319CB

The Drug Delivery Systems Market was valued at USD 37.04 billion in 2023, expected to reach USD 39.02 billion in 2024, and is projected to grow at a CAGR of 5.70%, to USD 54.61 billion by 2030.

The scope of drug delivery systems encompasses the technologies used for the targeted delivery and controlled release of therapeutic agents. These systems are vital for enhancing the efficacy, safety, and patient compliance of pharmaceutical treatments by ensuring that drugs reach their intended site of action in optimal concentrations. Drug delivery systems are applied across various modalities including oral, injectable, transdermal, inhalation, and implantable devices, catering to a broad end-use base in hospitals, clinics, and home care settings. The necessity of sophisticated drug delivery mechanisms is underscored by the ongoing demand for more precise, efficient, and patient-friendly treatment solutions, fueled by advancements in biotechnology and nanotechnology.

KEY MARKET STATISTICS
Base Year [2023] USD 37.04 billion
Estimated Year [2024] USD 39.02 billion
Forecast Year [2030] USD 54.61 billion
CAGR (%) 5.70%

Key growth factors influencing this market include increasing prevalence of chronic diseases, growing demand for biologics and biosimilars, and technological innovations in delivery techniques. Additionally, the rise in personalized medicine and biologic therapies presents significant opportunities for novel delivery systems that improve targeted action and bioavailability. For instance, innovations such as smart drug delivery platforms and microparticle technologies are potential areas with high growth prospects. Businesses looking to capitalize on these opportunities should invest in R&D for cutting-edge systems like biodegradable polymers and nanocarriers. However, the market faces challenges from regulatory complexities, high developmental costs, and limitations in biotechnology knowledge, which can impede the rate of innovation and adoption.

Limitations in drug stability and patient adherence also pose hurdles that need addressing. Future innovation should focus on overcoming these barriers by enhancing materials science and engineering developments to create more adaptive and responsive delivery systems. Exploring the synergistic use of digital health technologies can further refine monitoring and management, enhancing the drug delivery landscape. Overall, the drug delivery systems market is both dynamic and challenging, requiring strategic investments in technology and regulatory navigation to seize emerging opportunities and drive sustained market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Drug Delivery Systems Market

The Drug Delivery Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of chronic & infectious diseases across the globe
    • Rising investment government support for healthcare infrastructure
    • Upsurge in the demand for personalized medicine
  • Market Restraints
    • High cost associated with development of drug delivery systems
  • Market Opportunities
    • Technological advancements in the production of drug delivery systems
    • Growing adoption of nanotechnology for efficient targeted drug delivery systems
  • Market Challenges
    • Regulatory hurdles and time-consuming approval processes

Porter's Five Forces: A Strategic Tool for Navigating the Drug Delivery Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Drug Delivery Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Drug Delivery Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Drug Delivery Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Drug Delivery Systems Market

A detailed market share analysis in the Drug Delivery Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Drug Delivery Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Drug Delivery Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Drug Delivery Systems Market

A strategic analysis of the Drug Delivery Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Drug Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AptarGroup, Inc., AstraZeneca Plc, Boston Scientific Corporation, Cospheric LLC, DelSiTech Ltd., Enable Injections, Inc., F. Hoffmann-La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Merck KGaA, Merit Medical Systems, Inc., Novartis AG, Pacira BioSciences, Inc., Pfizer Inc., Polysciences Inc., Sanofi S.A., SHL Medical, Societal CDMO by CoreRx, Inc., Terumo Corporation, Thermo Fisher Scientific Inc., and West Pharmaceutical Services, Inc..

Market Segmentation & Coverage

This research report categorizes the Drug Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Delivery Type, market is studied across Inhalation Drug Delivery, Injection-Based Delivery, Nasal Drug Delivery, Ocular Drug Delivery, Oral Drug Delivery, Topical Drug Delivery, and Transdermal Drug Delivery.
  • Based on Formulation, market is studied across Gas, Liquid, Semisolid, and Solid.
  • Based on Drug Release Mechanism, market is studied across Controlled Release, Immediate Release, Sustained Release, and Targeted Release.
  • Based on Application, market is studied across Cardiovascular Diseases, Central Nervous System Disorders, Diabetes, Infectious Diseases, Oncology, and Respiratory Diseases.
  • Based on End-User, market is studied across Diagnostic Centers, Home Care Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of chronic & infectious diseases across the globe
      • 5.1.1.2. Rising investment government support for healthcare infrastructure
      • 5.1.1.3. Upsurge in the demand for personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with development of drug delivery systems
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the production of drug delivery systems
      • 5.1.3.2. Growing adoption of nanotechnology for efficient targeted drug delivery systems
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles and time-consuming approval processes
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Delivery Type: Growing adoption transdermal drug delivery to ensure prolonged and controlled drug release
    • 5.2.2. Application: Growing prevalence of diabetes globally push need for continuous drug delivery system
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Drug Delivery Systems Market, by Delivery Type

  • 6.1. Introduction
  • 6.2. Inhalation Drug Delivery
  • 6.3. Injection-Based Delivery
  • 6.4. Nasal Drug Delivery
  • 6.5. Ocular Drug Delivery
  • 6.6. Oral Drug Delivery
  • 6.7. Topical Drug Delivery
  • 6.8. Transdermal Drug Delivery

7. Drug Delivery Systems Market, by Formulation

  • 7.1. Introduction
  • 7.2. Gas
  • 7.3. Liquid
  • 7.4. Semisolid
  • 7.5. Solid

8. Drug Delivery Systems Market, by Drug Release Mechanism

  • 8.1. Introduction
  • 8.2. Controlled Release
  • 8.3. Immediate Release
  • 8.4. Sustained Release
  • 8.5. Targeted Release

9. Drug Delivery Systems Market, by Application

  • 9.1. Introduction
  • 9.2. Cardiovascular Diseases
  • 9.3. Central Nervous System Disorders
  • 9.4. Diabetes
  • 9.5. Infectious Diseases
  • 9.6. Oncology
  • 9.7. Respiratory Diseases

10. Drug Delivery Systems Market, by End-User

  • 10.1. Introduction
  • 10.2. Diagnostic Centers
  • 10.3. Home Care Settings
  • 10.4. Hospitals & Clinics

11. Americas Drug Delivery Systems Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Drug Delivery Systems Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Drug Delivery Systems Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Schott Pharma and Koru Medical Systems Partner to Innovate Drug Delivery for Improved Patient Care
    • 14.3.2. Difgen Boosts Production and Quality with Acquisition of FDA-Registered Facility
    • 14.3.3. Sharps Technology Launches New Drug Delivery Systems to Enhance Patient Safety and Reduce Administration Risks
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AptarGroup, Inc.
  • 3. AstraZeneca Plc
  • 4. Boston Scientific Corporation
  • 5. Cospheric LLC
  • 6. DelSiTech Ltd.
  • 7. Enable Injections, Inc.
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Insulet Corporation
  • 10. Johnson & Johnson Services, Inc.
  • 11. Lonza Group Ltd.
  • 12. Merck KGaA
  • 13. Merit Medical Systems, Inc.
  • 14. Novartis AG
  • 15. Pacira BioSciences, Inc.
  • 16. Pfizer Inc.
  • 17. Polysciences Inc.
  • 18. Sanofi S.A.
  • 19. SHL Medical
  • 20. Societal CDMO by CoreRx, Inc.
  • 21. Terumo Corporation
  • 22. Thermo Fisher Scientific Inc.
  • 23. West Pharmaceutical Services, Inc.

LIST OF FIGURES

  • FIGURE 1. DRUG DELIVERY SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG DELIVERY SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DRUG DELIVERY SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG DELIVERY SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INHALATION DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INJECTION-BASED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY NASAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY OCULAR DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ORAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TOPICAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TRANSDERMAL DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY GAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SEMISOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SOLID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY TARGETED RELEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY RESPIRATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DRUG DELIVERY SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DELIVERY TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY DRUG RELEASE MECHANISM, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM DRUG DELIVERY SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. DRUG DELIVERY SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 246. DRUG DELIVERY SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023